InfuSystem Holdings IncINFU
Price$12.82Intrinsic value$9.3227% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $143.3M+6.3% YoYTTM through 30 Jun 2026
Net Income $8.5M+264.3% YoYTTM through 30 Jun 2026
Free Cash Flow $22.9MTTM through 30 Jun 2026

Margins

Current
Gross Margin58.4%
EBITDA Margin18.4%
Operating Margin4.8%
Net Margin6.0%

Returns

13.5%ROE
8.0%ROA
10.2%ROIC

Balance Sheet Health

Debt / Equity0.33x
Current Ratio2.14x
Net Debt$17.5M
Cash & Equivalents$964K

Quality Metrics

Altman Z-Score5.44
Piotroski F-Score8 / 9
FCF Margin16.0%
Rule of 4017.0
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $143.4M
Diluted EPS$0.40TTM
'19'20'21'22'23'24'25
FY2025: $0.31

Dividend

No dividend

Capital Allocation

Capex Intensity0.3%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.